Pharmaceutics,
Journal Year:
2024,
Volume and Issue:
16(7), P. 921 - 921
Published: July 10, 2024
The
gut
microbiota
is
closely
associated
with
human
health,
and
alterations
in
can
influence
various
physiological
pathological
activities
the
body.
Therefore,
regulation
has
become
an
important
strategy
current
disease
treatment,
albeit
facing
numerous
challenges.
Nanomaterials,
owing
to
their
excellent
protective
properties,
drug
release
capabilities,
targeting
abilities,
good
biocompatibility,
have
been
widely
developed
utilized
pharmaceuticals
dietary
fields.
In
recent
years,
significant
progress
made
research
on
utilizing
nanomaterials
assist
regulating
for
intervention.
This
review
explores
latest
advancements
application
of
offers
insights
into
future
development
modulating
microbiota.
Nanomedicine,
Journal Year:
2024,
Volume and Issue:
19(2), P. 163 - 179
Published: Jan. 1, 2024
Background
&
aims:
Inflammatory
bowel
disease
(IBD)
is
a
condition
characterized
by
chronic
inflammation
of
the
gastrointestinal
tract,
manifesting
as
either
Crohn's
(CrD)
or
ulcerative
colitis
(UC).
Current
treatment
options
for
CrD
and
UC
primarily
focus
on
symptom
management.
In
recent
years,
advancements
in
nanotechnology
have
increased
clinical
applicability
nanoparticles
(NPs)
treating
IBD.
This
review
explores
current
research
NP-mediated
drug-delivery
systems
IBD
assesses
its
advantages
limitations.
Results:
The
authors
examine
diverse
nanomedicine
applications
address
challenges
prospects
field
to
advance
nanomediated
therapies
future.
Conclusion:
Innovative
NP-based
strategies
promise
reliable
effective
approach
Pharmaceutics,
Journal Year:
2024,
Volume and Issue:
16(7), P. 921 - 921
Published: July 10, 2024
The
gut
microbiota
is
closely
associated
with
human
health,
and
alterations
in
can
influence
various
physiological
pathological
activities
the
body.
Therefore,
regulation
has
become
an
important
strategy
current
disease
treatment,
albeit
facing
numerous
challenges.
Nanomaterials,
owing
to
their
excellent
protective
properties,
drug
release
capabilities,
targeting
abilities,
good
biocompatibility,
have
been
widely
developed
utilized
pharmaceuticals
dietary
fields.
In
recent
years,
significant
progress
made
research
on
utilizing
nanomaterials
assist
regulating
for
intervention.
This
review
explores
latest
advancements
application
of
offers
insights
into
future
development
modulating
microbiota.
